Translate page

WorldHealthDay 2020April 2020 - Today is World Health Day recognising the work of nurses and midwives. In these extraordinary times during the novel coronavirus outbreak we would also like to take the opportunity to acknowledge the incredible work of all the nurses, physicians and healthcare providers looking after people with CML all over the world.

We sincerely thank you for the work you are doing.

CoronavirusApril 2020 - In this ever changing pandemic keeping up to date with reliable information is important. In this spirit we share with you some frequently asked questions and answers about CML and COVID-19 put together by Dr Delphine Réa from Saint-Louis University Hospital, Paris. This was written on behalf of the European Heamatology Association CML Scientific Working Group on 29th March and is shared with permission.

It is important to note that the questions and answers below refer to chronic phase CML. Management of accelerated phase, blast crisis or post-transplant should be discussed in detail with the clinical team.

March 2020 - At present we do not have data on CML patients who have been infected with COVID-19. To help gather CML specific information, the iCMLf is collecting details of CML patients diagnosed with COVID-19. 

Please email with these details.

 DSC3535March 2020 - Inlight of the current COVID-19 pandemic we like to keep you updated with the Foundation’s activities and plans that reflect our commitment to the CML community over the coming weeks and months.

Unfortunately we have made the difficult decision to postpone all of the clinical preceptorships planned for the first half of this year and to re-evaluate the remainder in June.

CoronavirusMarch 2020 - For many people with CML, the reporting on the current public health emergency with the COVID-19 virus, also known as coronavirus, may be a source of anxiety. In light of this, the iCMLf is sharing an expert statement specifically for chronic phase CML patients on the novel coronavirus and the COVID-19 disease.

Please read the full statement below.

We will be keeping you updated as more information becomes available. If you have specific questions please email Physicians can post specific patient cases for advice and discussion on the iCMLf clinical case discussion forum.

Find more information on COVID-19 and CML on the iCMLf COVID-19 Hub

02 DSC 3070 Kopie

March 2020 - The iCMLf awards the 2020 iCMLf Prize to Dr Sabira Kurtovic, a hematologist at the Clinical Centre of the University of Sarajevo, Bosnia and Herzegovina.

This iCMLf Prize recognises outstanding contributions to the improvement of CML treatment under the challenging conditions of low- and middle-income countries with unequal access to monitoring and treatment. Dr Kurtovic is awarded the iCMLf Prize for her tireless work to ensure that patients with CML in Bosnia and Herzegovina receive the best possible care and have access to treatment with tyrosine kinase inhibitors (TKIs).

"I am thrilled and delighted that Dr Kurtovic will receive the 2020 iCMLf Prize. She has demonstrated a humanitarian spirit and drive through war and beyond, managing always to keep patient welfare at the forefront. Having worked with her I know first hand her dedication, intelligence, and compassion."
(Professor Jerry Radich, Fred Hutchinson Cancer Research Centre)